Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
In patients with androgeri-sensitive prostate cancer androgen-deprivation therapy leads to apoptosis of hormone-dependent cells but it may select out androgen-refractory clones. The apoptosis of prostate cancer cells induced by quinazoline-derived alpha1-adrenoceptor antagonists (doxazosin, terazosin, prazosin) counteracts cell proliferation and may have the potential of reversing or delaying prostate cancer growth. Elucidation of the biomolecular mechanisms whereby quinazoline-alpha1-adrenoceptor-antagonists are able to induce anoikis and apoptosis in androgen-refractory prostate cancer cells would be favorable for designing effective therapeutic regimens in the management of advanced prostate cancer.